Atopic dermatitis (AD) is associated with cutaneous dysbiosis, barrier defects, and immune
dysregulation, but the interplay between these factors needs further study. Early-onset …

Background Atopic dermatitis (AD) is a common skin disease affecting up to 20% of the
global population, with significant clinical heterogeneity and limited information about …

Background Microbial dysbiosis with increased Staphylococcus aureus (S. aureus)
colonization on the skin is a hallmark of atopic dermatitis (AD), however most microbiome …

Atopic dermatitis (AD) is a common inflammatory dermatosis affecting up to 30% of children
and 10% of adults worldwide. AD is primarily driven by an epidermal barrier defect which …

It is well established that different sites in healthy human skin are colonized by distinct
microbial communities due to different physiological conditions. However, few studies have …

LETTERS TO THE EDITOR 1643 such as the skin microbiota, have been described as risk
factors for AD. 3, 4 Reduction of microbiome diversity, accompanied by an increase in …

Atopic dermatitis (AD) is a common chronic inflammatory skin disease affecting~ 10–20% of
the general population. AD is characterized by disturbances in epidermal barrier function …

Atopic diathesis encompassing atopic dermatitis (AD), allergic rhinoconjunctivitis, food
allergy, eosinophilic esophagitis, and asthma is a widely prevalent condition with a broad …

Atopic dermatitis (AD) is a multifactorial, heterogeneous disease characterized by epidermal
barrier dysfunction, immune system dysregulation, and skin microbiome alterations. Skin …

Background Atopic dermatitis (AD) is characterized by an altered skin microbiome
dominantly colonized by S. aureus. Standard treatment includes emollients, anti …